Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Ethyl 3-aminopropanoate hydrochloride is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

4244-84-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 4244-84-2 Structure
  • Basic information

    1. Product Name: Ethyl 3-aminopropanoate hydrochloride
    2. Synonyms: beta-Alanine Ethyl Ester Hydrochloride, 95+%;H-S-Ala-OEt.HCl;β-Alanine ethyleester hydrochloride;3-AMINOPROPIONIC ACID ETHYL ESTER HYDROCHLORIDE;BETA-ALANINE ETHYL ESTER HCL;BETA-ALANINE ETHYL ESTER HYDROCHLORIDE;BETA-ALANINE-OET HCL;B-ALANINE ETHYL ESTER HCL
    3. CAS NO:4244-84-2
    4. Molecular Formula: C5H12NO2*Cl
    5. Molecular Weight: 153.61
    6. EINECS: 224-203-0
    7. Product Categories: Thiophenes ,Thiazolines/Thiazolidines;Amino Acids Derivatives;Aliphatics;Esters;β-Alanine [β-Ala];Amino Acids and Derivatives;Amino hydrochloride
    8. Mol File: 4244-84-2.mol
  • Chemical Properties

    1. Melting Point: 67-70 °C(lit.)
    2. Boiling Point: 167.8 °C at 760 mmHg
    3. Flash Point: 41.4 °C
    4. Appearance: White to off-white/Crystalline Powder
    5. Density: N/A
    6. Vapor Pressure: 1.67mmHg at 25°C
    7. Refractive Index: N/A
    8. Storage Temp.: Store at RT.
    9. Solubility: N/A
    10. Water Solubility: almost transparency
    11. Sensitive: Hygroscopic
    12. BRN: 3559095
    13. CAS DataBase Reference: Ethyl 3-aminopropanoate hydrochloride(CAS DataBase Reference)
    14. NIST Chemistry Reference: Ethyl 3-aminopropanoate hydrochloride(4244-84-2)
    15. EPA Substance Registry System: Ethyl 3-aminopropanoate hydrochloride(4244-84-2)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 36/37/39-26-22-36-24/25
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: HYGROSCOPIC
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 4244-84-2(Hazardous Substances Data)

4244-84-2 Usage

Chemical Properties

White to off-white crystalline powder

Check Digit Verification of cas no

The CAS Registry Mumber 4244-84-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,2,4 and 4 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 4244-84:
(6*4)+(5*2)+(4*4)+(3*4)+(2*8)+(1*4)=82
82 % 10 = 2
So 4244-84-2 is a valid CAS Registry Number.
InChI:InChI=1/C5H11NO2/c1-2-8-5(7)3-4-6/h2-4,6H2,1H3/p+1

4244-84-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A17277)  beta-Alanine ethyl ester hydrochloride, 98%   

  • 4244-84-2

  • 10g

  • 489.0CNY

  • Detail
  • Alfa Aesar

  • (A17277)  beta-Alanine ethyl ester hydrochloride, 98%   

  • 4244-84-2

  • 50g

  • 1830.0CNY

  • Detail
  • Alfa Aesar

  • (A17277)  beta-Alanine ethyl ester hydrochloride, 98%   

  • 4244-84-2

  • 250g

  • 7746.0CNY

  • Detail
  • Aldrich

  • (306142)  β-Alanineethylesterhydrochloride  98%

  • 4244-84-2

  • 306142-10G

  • 404.82CNY

  • Detail
  • Aldrich

  • (306142)  β-Alanineethylesterhydrochloride  98%

  • 4244-84-2

  • 306142-50G

  • 1,607.58CNY

  • Detail

4244-84-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl 3-aminopropanoate hydrochloride

1.2 Other means of identification

Product number -
Other names ethyl 3-aminopropanoate,hydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4244-84-2 SDS

4244-84-2Synthetic route

ethanol
64-17-5

ethanol

β-alanine hydrochloride
6057-90-5

β-alanine hydrochloride

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

Conditions
ConditionsYield
Stage #1: ethanol With thionyl chloride at -10℃; for 0.5h;
Stage #2: β-alanine hydrochloride In ethanol at -10 - 40℃;
99%
ethyl 2-cyanoacetate
105-56-6

ethyl 2-cyanoacetate

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

Conditions
ConditionsYield
With hydrogenchloride; hydrogen In 1,4-dioxane; ethanol at 60 - 70℃; under 375.038 Torr; for 18h; Flow reactor;97%
3-azidopropionic acid ethyl ester
40139-55-7

3-azidopropionic acid ethyl ester

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

Conditions
ConditionsYield
With triphenylphosphine In tetrahydrofuran; water for 12h; Ambient temperature;90%
ethanol
64-17-5

ethanol

3-amino propanoic acid
107-95-9

3-amino propanoic acid

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

Conditions
ConditionsYield
With thionyl chloride at -10℃; for 2h; Reflux;87%
With hydrogenchloride at 0℃; for 0.5h;
With thionyl chloride at -5 - 78℃; for 1.5h; Reflux;
ethyl 4-amino-4- oxobutanoate
53171-35-0

ethyl 4-amino-4- oxobutanoate

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

Conditions
ConditionsYield
With hydrogenchloride; bis-[(trifluoroacetoxy)iodo]benzene 1) acetonitrile, water, 60-62 deg C, 2) water; Yield given. Multistep reaction;
Ethyl 3-bromopropionate
539-74-2

Ethyl 3-bromopropionate

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 84 percent / NaN3 / dimethylsulfoxide / Ambient temperature
2: 90 percent / triphenylphosphine / tetrahydrofuran; H2O / 12 h / Ambient temperature
View Scheme
3-(tert-butyloxycarbonylamino)propionic acid
3303-84-2

3-(tert-butyloxycarbonylamino)propionic acid

ethyl acetate
141-78-6

ethyl acetate

A

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

B

β-alanine hydrochloride
6057-90-5

β-alanine hydrochloride

Conditions
ConditionsYield
With hydrogenchloride
(3R)-1-{3-[1-(tert-butoxycarbonyl)-4-piperidinyl]propanoyl}-3-piperidinecarboxylic acid
169498-28-6

(3R)-1-{3-[1-(tert-butoxycarbonyl)-4-piperidinyl]propanoyl}-3-piperidinecarboxylic acid

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

N-[(R)-1-{3-(1-tert-butoxycarbonyl-4-piperidyl)-propionyl}-3-piperidylcarbonyl]-β-alanine ethyl ester
169495-73-2

N-[(R)-1-{3-(1-tert-butoxycarbonyl-4-piperidyl)-propionyl}-3-piperidylcarbonyl]-β-alanine ethyl ester

Conditions
ConditionsYield
With benzotriazol-1-ol; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide In N,N-dimethyl-formamide at 20℃;100%
ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

benzyl chloroformate
501-53-1

benzyl chloroformate

3-Benzyloxycarbonylamino-propionic acid ethyl ester
161617-96-5

3-Benzyloxycarbonylamino-propionic acid ethyl ester

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 15h;100%
With sodium hydroxide In tetrahydrofuran; water at 0 - 5℃;
ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

1-chloro-2,6-dinitrobenzene
606-21-3

1-chloro-2,6-dinitrobenzene

ethyl N-(2,6-dinitrophenyl)-β-alaninate
1173982-96-1

ethyl N-(2,6-dinitrophenyl)-β-alaninate

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 20℃; for 2h;100%
With triethylamine In tetrahydrofuran at 20℃; for 2h;
2-(4'-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)-2-chlorobiphenyl-4-yl)-acetic acid
1259022-06-4

2-(4'-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)-2-chlorobiphenyl-4-yl)-acetic acid

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

ethyl 3-(2-(4'-(6-carbamoyl-3,5-dimethylpyrazin-2-yl)-2-chlorobiphenyl-4-yl)acetamido)propanoate
1259023-07-8

ethyl 3-(2-(4'-(6-carbamoyl-3,5-dimethylpyrazin-2-yl)-2-chlorobiphenyl-4-yl)acetamido)propanoate

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 20h;100%
2,6-dicholoro-3-nitropyridine
16013-85-7

2,6-dicholoro-3-nitropyridine

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

ethyl 3-((6-chloro-3-nitropyridin-2-yl)amino)propanoate
433226-12-1

ethyl 3-((6-chloro-3-nitropyridin-2-yl)amino)propanoate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃;100%
tert-butyl (1-(4-(6-chloro-5-nitro-3-phenylpyridin-2-yl)phenyl)cyclobutyl)carbamate
1313440-75-3

tert-butyl (1-(4-(6-chloro-5-nitro-3-phenylpyridin-2-yl)phenyl)cyclobutyl)carbamate

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

ethyl 3-((6-(4-(1-((tert-butoxycarbonyl)amino)cyclobutyl)phenyl)-3-nitro-5-phenylpyridin-2-yl)amino)propanoate
1313441-20-1

ethyl 3-((6-(4-(1-((tert-butoxycarbonyl)amino)cyclobutyl)phenyl)-3-nitro-5-phenylpyridin-2-yl)amino)propanoate

Conditions
ConditionsYield
With triethylamine In ethanol at 80℃; for 1.5h; Microwave irradiation; Inert atmosphere;100%
ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

succinimide 4-azidosalicylate
96602-46-9

succinimide 4-azidosalicylate

N-(4-azido salicyloyl)-β-alanine ethyl ester

N-(4-azido salicyloyl)-β-alanine ethyl ester

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane for 1h;99%
ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

2-[2-(2-methoxyethoxy)ethoxy]ethyl chloroformate
105292-71-5

2-[2-(2-methoxyethoxy)ethoxy]ethyl chloroformate

3-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxycarbonylamino}-propionic acid ethyl ester
469887-98-7

3-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxycarbonylamino}-propionic acid ethyl ester

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 18h;99%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

3-tert-butoxycarbonylamino-propionic acid ethyl ester
88574-53-2

3-tert-butoxycarbonylamino-propionic acid ethyl ester

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 0 - 60℃; for 6h;99%
With triethylamine In dichloromethane at 0 - 20℃; Inert atmosphere;94%
Stage #1: ethyl β-alaninate hydrochloride With triethylamine In dichloromethane at 0℃; for 0.5h;
Stage #2: di-tert-butyl dicarbonate In dichloromethane at 0 - 20℃; for 16h;
92%
4-chloro-2-(2'-ethoxybiphenyl-4-yl)-6-fluoroquinoline-3-carbonitrile
881312-98-7

4-chloro-2-(2'-ethoxybiphenyl-4-yl)-6-fluoroquinoline-3-carbonitrile

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

ethyl N-[3-cyano-2-(2'-ethoxybiphenyl-4-yl)-6-fluoroquinolin-4-yl]-beta-alaninate

ethyl N-[3-cyano-2-(2'-ethoxybiphenyl-4-yl)-6-fluoroquinolin-4-yl]-beta-alaninate

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 20℃; for 0.5h;99%
ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

chloroacetyl chloride
79-04-9

chloroacetyl chloride

ethyl 3-(N-chloroacetylamino)propionate
66368-59-0

ethyl 3-(N-chloroacetylamino)propionate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 5h;99%
2-amino-4-chloro-6-(piperidin-1-yl)pyrimidine-5-carbaldehyde
865660-47-5

2-amino-4-chloro-6-(piperidin-1-yl)pyrimidine-5-carbaldehyde

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

C15H23N5O3
1431987-97-1

C15H23N5O3

Conditions
ConditionsYield
With potassium carbonate for 21h;99%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

acrylonitrile
107-13-1

acrylonitrile

ethyl 3-((tert-butoxycarbonyl)(2-cyanoethyl)amino)propanoate
266353-22-4

ethyl 3-((tert-butoxycarbonyl)(2-cyanoethyl)amino)propanoate

Conditions
ConditionsYield
Stage #1: ethyl β-alaninate hydrochloride; acrylonitrile With sodium hydroxide In methanol at 70℃; for 6h;
Stage #2: di-tert-butyl dicarbonate In methanol at 0 - 20℃; for 6h;
99%
Stage #1: ethyl β-alaninate hydrochloride; acrylonitrile With sodium hydroxide In methanol at 70℃; for 6h;
Stage #2: di-tert-butyl dicarbonate In methanol at 0 - 20℃; for 6h;
638 g
Stage #1: ethyl β-alaninate hydrochloride; acrylonitrile With sodium hydroxide In methanol at 70℃; for 6h;
Stage #2: di-tert-butyl dicarbonate In methanol at 0 - 20℃; for 6h;
638 g
(R)-3-((4-(3-(2-((tert-butoxycarbonyl)amino)-2-phenylethyl)-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)piperazin-1-yl)methyl)benzoic acid
1308380-51-9

(R)-3-((4-(3-(2-((tert-butoxycarbonyl)amino)-2-phenylethyl)-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)piperazin-1-yl)methyl)benzoic acid

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

(R)-ethyl 3-(3-((4-(3-(2-((tert-butoxycarbonyl)amino)-2-phenylethyl)-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)piperazin-1-yl)methyl)benzamido)propanoate

(R)-ethyl 3-(3-((4-(3-(2-((tert-butoxycarbonyl)amino)-2-phenylethyl)-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)piperazin-1-yl)methyl)benzamido)propanoate

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 6h;99%
Indole-2-carboxylic acid
1477-50-5

Indole-2-carboxylic acid

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

3-[(1H-indole-2-carbonyl)amino]propionic acid ethyl ester
68724-78-7

3-[(1H-indole-2-carbonyl)amino]propionic acid ethyl ester

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 0 - 20℃; for 24h;98%
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 0 - 20℃; for 24h; Condensation;95%
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 0 - 20℃; for 24h; Inert atmosphere;90%
6,8-nonadecadiynoic acid
26192-19-8

6,8-nonadecadiynoic acid

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

ethyl 3-nonadeca-6,8-diynamidopropanoate

ethyl 3-nonadeca-6,8-diynamidopropanoate

Conditions
ConditionsYield
Stage #1: 6,8-octadecadiynoic acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 1h;
Stage #2: ethyl β-alaninate hydrochloride With triethylamine In dichloromethane at 0 - 20℃; for 3h;
98%
ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

(Z)-2-{4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]benzyloxyimino}-2-phenylacetic acid
250600-98-7

(Z)-2-{4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]benzyloxyimino}-2-phenylacetic acid

ethyl (Z)-3-(2-{4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]benzyloxyimino}-2-phenylacetoamido)propionate

ethyl (Z)-3-(2-{4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]benzyloxyimino}-2-phenylacetoamido)propionate

Conditions
ConditionsYield
With benzotriazol-1-ol; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide; triethylamine In N,N-dimethyl-formamide at 20℃; for 18h;97%
pyrrol-2-yl trichloromethyl ketone
35302-72-8

pyrrol-2-yl trichloromethyl ketone

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

3-[(1H-pyrrole-2-carbonyl)-amino]-propionic acid ethyl ester
129053-83-4

3-[(1H-pyrrole-2-carbonyl)-amino]-propionic acid ethyl ester

Conditions
ConditionsYield
With triethylamine In acetonitrile at 20℃; for 48h;97%
With diisopropylamine In tetrahydrofuran at 20℃; for 7h; Inert atmosphere; Reflux;63%
With triethylamine In acetonitrile at 20℃;
With triethylamine In acetonitrile at 20℃;
With triethylamine
3-nitro-benzoyl glycine
617-10-7

3-nitro-benzoyl glycine

di(succinimido) carbonate
74124-79-1

di(succinimido) carbonate

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

N-[2-[[(3-nitrophenyl)carbonyl]amino]-1-oxoethyl]-β-alanine

N-[2-[[(3-nitrophenyl)carbonyl]amino]-1-oxoethyl]-β-alanine

Conditions
ConditionsYield
With N,N-dimethylamino-pyridine In N-methyl-acetamide; aqueous potassium carbonate97%
ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

benzyl bromide
100-39-0

benzyl bromide

ethyl 3-(dibenzylamino)propanoate
108898-31-3

ethyl 3-(dibenzylamino)propanoate

Conditions
ConditionsYield
With potassium carbonate In acetonitrile at 40℃;97%
With potassium carbonate In acetonitrile at 40℃;97%
1-(1-(2',4',6'-trimethyl-[1,1'-biphenyl]-4-yl)butyl)-1H-indazole-5-carboxylic acid

1-(1-(2',4',6'-trimethyl-[1,1'-biphenyl]-4-yl)butyl)-1H-indazole-5-carboxylic acid

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

ethyl 3-(1-(1-(2',4',6'-trimethyl-[1,1'-biphenyl]-4-yl)butyl)-1H-indazole-5-carboxamido)propionic acid

ethyl 3-(1-(1-(2',4',6'-trimethyl-[1,1'-biphenyl]-4-yl)butyl)-1H-indazole-5-carboxamido)propionic acid

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 20℃; for 3h;96.7%
ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

4-amino salicylic acid N-hydroxysuccinimide ester

4-amino salicylic acid N-hydroxysuccinimide ester

N-(4-amino salicyloyl)-β-alanine ethyl ester

N-(4-amino salicyloyl)-β-alanine ethyl ester

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane for 2h;96%
N-Fmoc-β-alanine
35737-10-1

N-Fmoc-β-alanine

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

N-(9-fluorenylmethoxycarbonyl)-β-alanine-β-alanine ethyl ester
877066-64-3

N-(9-fluorenylmethoxycarbonyl)-β-alanine-β-alanine ethyl ester

Conditions
ConditionsYield
Stage #1: N-Fmoc-β-alanine With benzotriazol-1-ol; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide In dichloromethane at 4℃; for 0.5h;
Stage #2: ethyl β-alaninate hydrochloride With N-ethyl-N,N-diisopropylamine In dichloromethane at 22℃; for 16h;
96%
ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

N-(9-fluorenylmethoxycarbonyl)-β-alanine-β-alanine ethyl ester
877066-64-3

N-(9-fluorenylmethoxycarbonyl)-β-alanine-β-alanine ethyl ester

Conditions
ConditionsYield
Stage #1: N-Fmoc-β-alanine With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 0℃; for 0.5h;
Stage #2: ethyl β-alaninate hydrochloride With N-ethyl-N,N-diisopropylamine In dichloromethane at 23℃; for 16h;
96%
5-[(2,5-difluorophenyl)[(4-fluorophenyl)sulfonyl]methyl]-4-methylpyridine-2-carboxylic acid
913090-51-4

5-[(2,5-difluorophenyl)[(4-fluorophenyl)sulfonyl]methyl]-4-methylpyridine-2-carboxylic acid

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

N-[[5-[(2,5-difluorophenyl)[(4-fluorophenyl)sulfonyl]methyl]-4-methylpyridin-2-yl]carbonyl]-β-alanineethyl ester

N-[[5-[(2,5-difluorophenyl)[(4-fluorophenyl)sulfonyl]methyl]-4-methylpyridin-2-yl]carbonyl]-β-alanineethyl ester

Conditions
ConditionsYield
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 15h;96%
3-fluoro-4-nitrobenzonitrile
218632-01-0

3-fluoro-4-nitrobenzonitrile

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

3-(5-cyano-2-nitro-phenylamino)-propionic acid ethyl ester
1090902-55-8

3-(5-cyano-2-nitro-phenylamino)-propionic acid ethyl ester

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl acetamide at 20℃; for 16h;96%
5,6-dimethoxyindole-2-carboxylic acid
88210-96-2

5,6-dimethoxyindole-2-carboxylic acid

ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

3-[(5,6-dimethoxy-1H-indole-2-carbonyl)amino]propionic acid ethyl ester
1092796-32-1

3-[(5,6-dimethoxy-1H-indole-2-carbonyl)amino]propionic acid ethyl ester

Conditions
ConditionsYield
Stage #1: 5,6-dimethoxyindole-2-carboxylic acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In tetrahydrofuran at 20℃; for 8h;
Stage #2: ethyl β-alaninate hydrochloride With triethylamine In tetrahydrofuran at 20℃;
96%
ethyl β-alaninate hydrochloride
4244-84-2

ethyl β-alaninate hydrochloride

1-phenyl-1,6-dioxo-hepta-2,4-(E,E)-diene
160196-16-7

1-phenyl-1,6-dioxo-hepta-2,4-(E,E)-diene

ethyl 2-(2-oxophenylethyl)-5-methyl(pyrrol-1-yl)propionate
477335-96-9

ethyl 2-(2-oxophenylethyl)-5-methyl(pyrrol-1-yl)propionate

Conditions
ConditionsYield
With sodium carbonate In ethanol at 20℃; for 6h;95%

4244-84-2Relevant articles and documents

Juvenile hormone mimics with phenyl ether and amide functionality to be insect growth regulators (IGRs): synthesis, characterization, computational and biological study

Awasthi, Pamita,Devi, Vandna

, (2021/10/12)

A series of substituted phenyl ethers derivatives as juvenile hormone (JH) mimics (V1-V8) have been synthesized. Substituted phenoxyacetic acid and amino acid ethyl ester hydrochloride were prepared using NaOH, SOCl2. DCC method has been used for amide linkage. The structure of prepared compounds has been confirmed by Fourier Transform Infra-Red (FT-IR), Electrospray ionization-Mass spectrometry (ESI-MS), Proton and Carbon-13 nuclear magnetic resonance (1H-NMR, 13C-NMR) spectroscopic techniques. Biological efficacy of synthesized analogs has been carried out under laboratory conditions. Galleria mellonella (honey bee pest) has been chosen as testing insect. Juvenile hormone (JH) activity of synthesized compounds has been tested at different concentrations and compared with the standard juvenile hormone analogs (JHAs) pyriproxyfen (M1) and fenoxycarb (M2) against the fifth larval instar of G. mellonella. Compound ethyl 2-[2-(4-methylphenoxy)aminoacetyl]-3-phenyl-propanoate (V6) exhibited better activity among all the synthesized compounds (V1-V8) with LC50 and LC90 values of 0.11 mg/mL and 0.56 mg/mL respectively. Compounds showed insect growth regulating (IGR) activity at lower concentrations. In silico screening of all synthesized compounds with the W-cavity of juvenile hormone-binding protein (JHBP) of insect G. mellonella has been carried out. Chemical reactivity of synthesized series has been studied using DFT/B3LYP/6-311 + G(d,2p) method. Non-toxic behavior of molecules has also been observed from ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) study using discovery studio client 3.0. Communicated by Ramaswamy H. Sarma.

Turn Conformation of β-Amino Acid-Based Short Peptides Promoted by an Amidothiourea Moiety at C-Terminus

Zhang, Yanhan,Yan, Xiaosheng,Cao, Jinlian,Weng, Peimin,Miao, Daiyu,Li, Zhao,Jiang, Yun-Bao

, p. 9844 - 9849 (2020/09/03)

A C-terminal amidothiourea motif is shown to promote a β-turn-like folded conformation in a series of β-amino acid-based short peptides in both the solid state and solution phase by an intramolecular 11-membered ring hydrogen bond.

Selective Hydrogenation of Nitriles to Primary Amines Catalyzed by a Polysilane/SiO2-Supported Palladium Catalyst under Continuous-Flow Conditions

Saito, Yuki,Ishitani, Haruro,Ueno, Masaharu,Kobayashi, Shū

, p. 211 - 215 (2017/04/21)

Hydrogenation of nitriles to primary amines with heterogeneous catalysts under liquid-phase continuous-flow conditions is described. Newly developed polysilane/SiO2-supported Pd was found to be an effective catalyst and various nitriles were converted into primary amine salts in almost quantitative yields under mild reaction conditions. Interestingly, a complex mixture was obtained under batch conditions. Lifetime experiments showed that this catalyst remained active for more than 300 h (TON≥10 000) without loss of selectivity and no metal leaching from the catalyst occurred. By using this continuous-flow hydrogenation, synthesis of venlafaxine, an antidepressant drug, has been accomplished.

Ferrocene-modified amino acids: synthesis and in vivo bioeffects on hippocampus

Rodionov,Snegur,Simenel,Dobryakova, Yu. V.,Markevich

, p. 136 - 142 (2017/07/05)

A method for the ferrocene modification of amino acids of natural and synthetic origin has been developed. In the in vivo studies, the hippocampal electrical activity under the action of ferrocenyl(phenylpyrazolyl)glycine (1) was assessed. A meaningful rise (up to 25% compared to the control) in the response amplitudes of the focal potentials of the hippocampal region СА1 after intraperitoneal administration of compound 1 at the dose of 2.0 mg kg–1 was established.

Optical activity 1,5-substituted-1,3,5-hexahydrotriazine-2-N-nitroimines: Synthesis and insecticidal activity

Xue, Si-Jia,Bu, Hong-Fei,Liu, Li,Xu, Xiao,Ma, Xubo,Zhu, Jun

, p. 1067 - 1070 (2013/10/21)

Twelve novel neonicotinoid analogues 1-(2-furfuryl)-5-substituted-1,3,5- hexahydrotriazine-2-N-nitroimines 3a, 3b, 3c, 3d, 3e, 3f, 3g, 3h, 3i, 3j, 3k, 3l were synthesized. Their structures were characterized by 1H NMR, IR, and elemental analysis. The preliminary bioassay tests showed that all the title compounds gave ≥90% mortality against Nilaparvata lugen 500 mg/L.

Amide-based derivatives of β-alanine hydroxamic acid as histone deacetylase inhibitors: Attenuation of potency through resonance effects

Liao, Vivian,Liu, Tao,Codd, Rachel

supporting information, p. 6200 - 6204 (2012/10/29)

A library of amide-linked derivatives of β-alanine hydroxamic acid were prepared (2-7) and the activity as inhibitors of Zn(II)-containing histone deacetylases (HDACs) determined in vitro against HDAC1 and the anti-proliferative activity determined in BE(2)-C neuroblastoma cells. The IC50 values of the best-performing compounds (3-7) against HDAC1 ranged between 38 and 84 μM. The least potent compound (2) inhibited a maximum of only 40% HDAC1 activity at 250 μM. The anti-proliferative activity of 2-7 at 50 μM against BE(2)-C neuroblastoma cells ranged between 57.0% and 88.6%. The structural similarity between the potent HDAC inhibitor trichostatin A (TSA, 1; HDAC1, IC50 12 nM) and the present compounds (2-7) was high at the Zn(II) coordinating hydroxamic acid head group; and in selected compounds (2, 5), at the 4-(dimethylamino)phenyl tail. The significantly reduced potency of 2-7 relative to 1 underscores the rank importance of the linker region as part of the HDAC inhibitor pharmacophore. Molecular modeling of 1-7 using HDAC8 as the template suggested that the conformationally constrained 4′-methyl group of 1 may contribute to HDAC inhibitor potency through a sandwich-like interaction with a hydrophobic region containing F152 and F208; and that the absence of this group in 2-7 may reduce potency. The close proximity of the 5′-carbonyl oxygen atom in 2-7 to the sulfur atom of Met274 in HDAC8 or the corresponding isobutyl group of Leu274 in HDAC1 may attenuate potency through repulsive steric and dipole-dipole forces. In a unique resonance stabilized form of 2, this interaction could manifest as stronger ion-dipole repulsive forces, resulting in a further decrease in potency. This work suggests that resonance structures of HDAC inhibitors could modulate intermolecular interactions with HDAC targets, and potency.

Structure-activity relationship studies of 1-(4-chloro-2,5-dimethoxyphenyl) -3-(3-propoxypropyl)thiourea, a non-nucleoside reverse transcriptase inhibitor of human immunodeficiency virus type-1

Weitman, Michal,Lerman, Keti,Nudelman, Abraham,Major, Dan Thomas,Hizi, Amnon,Herschhorn, Alon

experimental part, p. 447 - 467 (2011/03/20)

The reverse transcriptase (RT) of the human immunodeficiency virus type-1 (HIV-1) is still a prime target for drug development due to the continuing need to block drug-resistant RT mutants by new inhibitors. We have previously identified 1-(4-chloro-2,5-dimethoxyphenyl)-3-(3-propoxypropyl)thiourea, compound 1, as a potent RT inhibitor from an available chemical library. Here, we further modified this compound to study structure-activity relationships when replacing various groups in the molecule. Different functional groups were systematically introduced on the aromatic ring and the aliphatic chain of the compound was modified. The effect of these modifications on viral infectivity was then evaluated. The most potent compound found was propyl 4-(amino-N-(4-chloro-2,5-dimethoxyphenyl)methanethioamino)butanoate, 45c, which inhibited infectivity with a calculated IC50 of about 1.1 μM. Docking studies identified potential important interactions between the top scoring ligands and HIV-1 RT, and the predicted relative affinity of the ligands was found to be in agreement with the experimental results.

Chiral 1,5-disubstituted 1,3,5-hexahydrotriazine-2-N-nitroimine analogues as novel potent neonicotinoids: Synthesis, insecticidal evaluation and molecular docking studies

Sun, Chuanwen,Zhu, Jun,Wang, Haifeng,Jin, Jia,Xing, Jiahua,Yang, Dingrong

experimental part, p. 11 - 20 (2011/02/27)

A new series of 1,5-disubstituted 1,3,5-hexahydrotriazine-2-N-nitroimines (4a-4x) were designed and synthesized as novel chiral neonicotinoid analogues. The single-crystal structure of 4n was further determined by X-ray diffraction, and its S configuration was confirmed. Preliminary bioassay showed that compound 4e, 4k, 4u, 4v exhibited excellent insecticidal activities at 100 mg/L, while 4k had >90% mortality at 10 mg/L, which suggested it could be used as a lead for future development. Modeling the inhibitor-nAChR complexes by molecular docking studies explained the structure-activity relationships observed in vitro, and revealed an intriguing molecular binding mode at the active site of nAChR, which raised the possibility that these analogues may arbitrate their insecticidal activity through a mechanism other than imidacloprid.

Anthranilic acid based CCK1 receptor antagonists: Blocking the receptor with the same 'words' of the endogenous ligand

Lassiani, Lucia,Pavan, Michela V.,Berti, Federico,Kokotos, George,Markidis, Theodoros,Mennuni, Laura,Makovec, Francesco,Varnavas, Antonio

experimental part, p. 2336 - 2350 (2009/09/05)

The anthranilic acid diamides represent the more recent class of nonpeptide CCK1 receptor antagonists. This class is characterized by the presence of anthranilic acid, used as a molecular scaffold, and two pharmacophores selected from the C-terminal tetrapeptide of CCK. The lead compound coded VL-0395, endowed with sub-micromolar affinity towards CCK1 receptors, was characterized by the presence of Phe and 2-indole moiety at the C- and N-termini of anthranilic acid, respectively. Herein we describe the first step of the anthranilic acid C-terminal optimization using, instead of Phe, aminoacids belonging to the primary structure of CCK-8 and other not coded residues. Thus we demonstrate that the CCK1 receptor affinity depends on the nature of the aminoacidic side chain as well as that the free carboxy group of the alpha-aminoacids is crucial for the binding. The R enantiomers of the most active compounds represent the eutomers of this class of antagonists confirming thus the stereo preference of the receptor. Moreover this SAR study demonstrates that the receptor binding pocket, that host the aminoacidic side chain, results much more tolerant respect to that accommodating the indole ring. As a result, an appropriate variation of the aminoacidic side chain could provide a better CCK1 receptor affinity diorthosis.

New access to racemic β3-amino acids

Nejman, Micha?,?liwińska, Anna,Zwierzak, Andrzej

, p. 8536 - 8541 (2007/10/03)

A general simple procedure having the potential for large scale preparations of racemic β3-amino acids has been developed. The procedure involves base-catalyzed Michael-type addition of sodium diethyl malonate to N-Boc-α-amidoalkyl-p-tolyl sulfones in tetrahydrofuran. Hydrolysis of the adducts by refluxing with 6 M aqueous hydrochloric acid affords β3-amino acid hydrochlorides in high yield and excellent purity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 4244-84-2